Stability of Pergolide Mesylate Oral Liquid at Room Temperature
Download in electronic PDF format for $75
Abstract: Pergolide mesylate (proprietary name Permax) is used to treat equine Cushing’s syndrome. Since pergolide mesylate has been removed from the market, the tablets are no longer available. Therefore, pergolide mesylate preparations have to be compounded for veterinary use. Compounded oral liquid formulations have been given arbitrary beyond-use dates of 14 days (aqueous) to 90 days (oil based). The goal of this study was to determine the stability of a 0.2 mg/mL pergolide oral liquid prepared according to a previously published formulation and stored at room temperature. The sample preparation and the high-performance liquid chromatographic assay described in the United States Pharmacopeia–National Formulary were modified to treat the oral liquid as a suspension. The assay was evaluated prior to its use. A linear relationship was found between peak area and concentration, with R2 values ranging from 0.989 to 0.999 for three of the sample calibration plots. The daily reproducibility and day-to-day variability of s
Related Keywords:
Brandon R. Shank, Clyde M. Ofner III, BS, PhD, RPh, pergolide mesylate, stability, storage temperature, equine Cushing syndrome, horses, formulation
Related Categories:
FORMULATIONS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, VETERINARY, DOSAGE FORMS/DRUG CARRIERS, STORAGE
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability of Pergolide Mesylate Oral Liquid at Room Temperature
Shank Brandon R, Ofner Clyde M III
|
May/Jun 2009
Pg. 254-258
|
Equine Cushing’s Syndrome
Vail Jane
|
Jan/Feb 2003
Pg. 27-29
|
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Newton David W
|
Jul/Aug 2019
Pg. 281-287
|
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 410
|
Pergolide 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 232
|
Pergolide 500-mcg Capsules, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 231
|
Room Temperature Stability of Injectable Succinylcholine Dichloride
Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
|
Jan/Feb 2008
Pg. 83-85
|
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Nahata Milap C
|
Sep/Oct 2015
Pg. 428-431
|
Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste
Dudley Richard, McDowell Brean, Mahl Carissa, Sarkar Arindam Basu
|
May/Jun 2012
Pg. 258-261
|
Calibration/Validation of Incubator Temperature
Allen Loyd V Jr
|
Mar/Apr 2004
Pg. 130-131
|
Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L, Stewart James T, Warren Flynn W
|
Sep/Oct 2002
Pg. 388-390
|
Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L, Stewart James T, Warren Flynn W
|
Nov/Dec 2002
Pg. 475-477
|
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
|
Jul/Aug 2022
Pg. 330-335
|
PreScription: Temperatures by Degrees
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 268
|
Equine Cushing's Disease: A Clinical Update
Bliss George
|
Sep/Oct 2007
Pg. 384-388
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
|
Jan/Feb 2021
Pg. 73-81
|
Standard Operating Procedure: Incubator Temperature Monitoring
Allen Loyd V Jr
|
May/Jun 2003
Pg. 228-229
|
Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography
Gupta Vishnu D
|
May/Jun 2000
Pg. 233-235
|
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Trissel Lawrence A, Zhang Yanping, Koontz Susannah E
|
Sep/Oct 2006
Pg. 396-399
|
Return to Top |